The Swiss government ordered 5 million doses of CureVac's mRNA vaccine against Covid-19 in February.
Keystone / Sebastian Gollnow
Swiss pharmaceutical giant Novartis has signed an initial deal to produce the mRNA molecules for the Covid-19 vaccine developed by German biotech firm CureVac.
This content was published on
2 minutes
Keystone-SDA/jdp
Português
pt
Multinacional Novartis vai ajudar a produzir vacina CureVac Covid-19
On Thursday, Novartis said its plant in Kundl, Austria, would start production of the CureVac vaccine (CVnCoV) this summer. It hopes to deliver enough drug substance to produce 50 million doses by the end of the year and plans to accelerate production to reach 200 million doses in 2022. CureVac is also working with German pharmaceutical company Bayer to manufacture its vaccine.
“We are currently expanding our site with additional capacities for the production of mRNA in order to best serve the increasing demand,” said Steffen Lang, Global Head of Novartis Technical Operations, in a press release.
At the end of January, Novartis announced it would also provide manufacturing capacity for Pfizer/BioNTech’s Covid-19 vaccine. Under the deal, Novartis is involved in the fill-and-finish process – taking the bulk mRNA active ingredient from BioNTech and putting it into vials at its facility in Stein, Switzerland.
Novartis says it is considering other agreements to support the global supply of Covid-19 vaccines and therapeutics.
Switzerland has reserved over 30 million vaccine doses from different manufacturers – Pfizer/BioNTech, Moderna, AstraZeneca, Curevac and Novavax – for its population of 8.6 million people. So far, there are two vaccines approved and available in the country, those from Pfizer/BioNTech and Moderna.
The Swiss government secured 5 million doses of the CureVac vaccine in February. It is based on similar mRNA technology as the Pfizer/BioNtech and Moderna vaccines. Swiss firm Lonza is producing the main active vaccine ingredients for the Moderna vaccine for non-US markets at its site in Visp in southern Switzerland.
Popular Stories
More
Swiss Politics
Swiss reject plans for bigger motorways and extra rights for landlords
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
Argentina’s Milei to visit Switzerland in January 2025
This content was published on
Argentina's libertarian President Javier Milei plans to visit Switzerland on January 24, 2025 to attend an event organised by the Liberal Institute in Zurich.
This content was published on
OpenAI, the maker of ChatGPT, says it intends to open an office in Zurich. The move is part of its European expansion plan, after setting up offices in London, Paris, Brussels and Dublin.
This content was published on
The Swiss economy is growing slightly faster than expected, according to the Organization for Economic Cooperation and Development (OECD).
This content was published on
The House of Representatives on Wednesday cut the foreign aid budget by CHF250 million ($282 million) in favour of the army.
Parliament confirms 13th pension payment to be paid once a year in December
This content was published on
The 13th old-age pension payment will be paid out as planned from December 2026, the Swiss Senate confirmed on Wednesday.
This content was published on
Around 1,000 Swiss farmers took part in a protest action near Bern on Tuesday, calling for less administrative work, more planning security and fairer prices.
UN appeals for more funds to assist 305 million people in need
This content was published on
The United Nations Office for the Coordination of Humanitarian Affairs (OCHA) estimates that around 305 million people will need aid in 2025.
Swiss authorities release right-to-die activist in Sarco ‘suicide capsule’ case
This content was published on
A right-to-die activist has been released from police custody over the reported first use of the Sarco “suicide capsule”, after prosecutors ruled out the possibility of an intentional homicide.
Switzerland demands immediate halt to hostilities in Syria
This content was published on
The Swiss foreign ministry has called for an immediate end to hostilities in Syria. International humanitarian law must be respected, it declared via the social media platform X on Tuesday.
Poll: right-wing Swiss People’s Party enjoys growing support among population
This content was published on
If national elections had been held in Switzerland last month, the right-wing Swiss People's Party would have won, and increased its share of votes by 2% compared to the 2023 federal elections.
Calls intensify for Big Pharma to break monopolies on Covid-19 vaccines
This content was published on
Pressure is mounting to suspend intellectual property rules to help vaccines reach more people. Can the WTO find a solution?
Novartis agrees to help Pfizer-BioNTech produce Covid-19 vaccine
This content was published on
Swiss pharma giant Novartis says it has signed an initial agreement to provide manufacturing capacity for Pfizer and BioNTech's Covid-19 vaccine.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.